Thromboembolism

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

FDA approval · 2023-08-01
FDA Approved: ARGATROBAN — Supplemental Application (Mylan Institutional LLC)
The FDA approved a supplemental application for Argatroban from Mylan Institutional LLC under ANDA 202626, expanding the use of this generic…